Hotchkis & Wiley Capital Management
CVS icon

Hotchkis & Wiley Capital Management’s CVS Health CVS Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201M Sell
2,794,787
-98,590
-3% -$7.59M 0.62% 49
2025
Q4 		$230M Buy
2,893,377
+13,130
+0.5% +$1.04M 0.69% 42
2025
Q3 		$217M Sell
2,880,247
-2,662,997
-48% -$183M 0.67% 48
2025
Q2 		$382M Sell
5,543,244
-2,233,908
-29% -$146M 1.24% 24
2025
Q1 		$527M Sell
7,777,152
-5,162,835
-40% -$309M 1.76% 15
2024
Q4 		$581M Buy
12,939,987
+1,042,953
+9% +$58.5M 1.93% 11
2024
Q3 		$748M Buy
11,897,034
+3,071,613
+35% +$179M 2.49% 5
2024
Q2 		$521M Buy
8,825,421
+2,177,631
+33% +$136M 1.82% 15
2024
Q1 		$530M Sell
6,647,790
-48,486
-0.7% -$3.7M 1.77% 18
2023
Q4 		$529M Sell
6,696,276
-152,810
-2% -$10.9M 1.88% 11
2023
Q3 		$478M Buy
6,849,086
+515,325
+8% +$36.5M 1.81% 14
2023
Q2 		$438M Buy
6,333,761
+1,002,920
+19% +$71.4M 1.63% 19
2023
Q1 		$396M Buy
5,330,841
+2,185,251
+69% +$183M 1.53% 20
2022
Q4 		$293M Sell
3,145,590
-165,548
-5% -$16M 1.13% 29
2022
Q3 		$316M Sell
3,311,138
-77,982
-2% -$7.72M 1.36% 24
2022
Q2 		$314M Sell
3,389,120
-82,084
-2% -$8.01M 1.25% 24
2022
Q1 		$351M Sell
3,471,204
-585,725
-14% -$61.5M 1.12% 28
2021
Q4 		$419M Buy
4,056,929
+369,746
+10% +$34.2M 1.32% 22
2021
Q3 		$313M Buy
3,687,183
+191,375
+5% +$16M 1% 36
2021
Q2 		$292M Buy
+3,495,808
New +$286M 0.89% 39

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management's CVS Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management reduced its CVS Health (CVS) stake by 3.4% in Q1 2026, selling an estimated $7.59M and leaving 2,794,787 shares worth $201M. The position accounts for 0.62% of the portfolio, ranked #49.

Hotchkis & Wiley Capital Management first reported a position in CVS in Q2 2021 and has held it in 20 quarters since. The position peaked at $748M in Q3 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Hotchkis & Wiley Capital Management held 2,794,787 shares of CVS Health worth $201M as of Q1 2026.
  • Hotchkis & Wiley Capital Management sold 98,590 CVS Health shares in Q1 2026, an estimated $7.59M.
  • CVS Health made up 0.62% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #49 holding.
  • Hotchkis & Wiley Capital Management first reported a position in CVS Health in Q2 2021 and has held it in 20 quarters since.
  • Hotchkis & Wiley Capital Management's CVS Health position peaked at $748M in Q3 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.